{"id":"W4408275973","doi":"10.1038/s41591-025-03559-0","title":"Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer’s disease: a randomized controlled phase 2a trial","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute on Aging","keywords":"Placebo; Medicine; Clinical endpoint; Atrophy; Adverse effect; Randomized controlled trial; Internal medicine; Neuroinflammation; Clinical trial; Cognitive decline; Gastroenterology; Surgery; Disease; Pathology; Dementia","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00161614,0.001568512,0.002444519,0.0004690642,0.0004646177,0.0007651176,0.0008646025,0.001934165,0.005364016],"category_scores_gemma":[0.001296924,0.0004188196,0.001494781,0.000355421,0.001085052,0.000776461,0.0003205408,0.002155219,0.0007921658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004614917,"about_ca_system_score_gemma":0.0009860576,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005750165,"about_ca_topic_score_gemma":0.001202883,"domain_scores_codex":[0.9994891,0.000282876,0.00002931939,0.00007868373,0.00004657879,0.00007348181],"domain_scores_gemma":[0.9993771,0.0001698921,0.0001462926,0.00004499397,0.00005290872,0.0002088665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9576902,0.009715941,0.0004515612,0.0009843776,0.0007726693,0.00006596038,0.00004898843,0.0003664669,0.004746615,0.0001723663,0.001321388,0.02366331],"study_design_scores_gemma":[0.9539775,0.04424512,0.0005519299,0.00002454069,0.0001746279,0.00002007567,0.000009818968,0.0001861017,0.0002887782,0.00008187698,0.000432473,0.000007227883],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9774408,0.008722974,0.001070689,0.001272514,0.0008204242,0.007033516,0.001173337,0.0002269308,0.002238816],"genre_scores_gemma":[0.9733532,0.00551975,0.002536911,0.002255438,0.0007908728,0.01048182,0.001290579,0.00003222669,0.003739319],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005364016,"threshold_uncertainty_score":0.01794446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02176076590645048,"score_gpt":0.358362807128838,"score_spread":0.3366020412223875,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}